IPMK and age-related macular degeneration: Additionally, disease-relevant connections have been identified: in both mouse models and patient tissues of age-related macular degeneration (AMD) [80], reduced levels of IPMK result in impaired HDAC3 activation, disrupted gene regulation, and increased proteostatic stress.